FDA Inspection 1010081 — Intrinsic Therapeutics, Inc.
The FDA completed an inspection of Intrinsic Therapeutics, Inc. on Mar 31, 2017 in Woburn, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 31, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Woburn, MA (United States)
Additional Details
Sponsor, Contract Research Organization